Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Clinical trial NCT04184518 · WITHDRAWN
Trial details
- NCT number
- NCT04184518
- Sponsor
- Grupo Español Multidisciplinar de Melanoma
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2021-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.